Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 June, 2009.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17-24 March, 2009.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon , 3-10 June 2014.
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon , 30 September - 7 October 2014.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 24 February - 3 March, 2009.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Chapter 6.1 includes National cancer control programs by Simon B. Sutcliffe and Cancer control in Canada: challenges and strategies in a high-income country.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Table of contents:; The Role of Complementary Medicine and Cancer Treatment -- Communicating with Your Medical Team -- How To Use This Book -- Descriptions of Complementary Medicine Therapies -- Aromatherapy -- Chinese Medicine and Acupressure -- Herbal Teas -- Homeopathy -- Massage -- Nutrition …
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | On Loan, due Thursday, April 25, 2024 |
c.1 BC Cancer Agency VAN Library | Available |
Benzene; Carbon monoxide; Formaldehyde; Naphthalene; Nitrogen dioxide; Polycyclic aromatic hydrocarbons; Radon; Trichloroethylene; Tetrachloroethylene
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
v.1: Sources : report of the United Nations Scientific Committee on the effects of atomic radiation to the General Assembly; Scientifc Annexes: Annex A: Medical radiation exposures; Annex B: Exposures of the public and workers from various sources of radiation
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 14-21 October 2008.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Table of Contents:; 1. Immunotherapy administration; 2. Immunotherapy; 3. Cancer immunotherapy; 4. CAR T-cell therapy; 5. Cytokine release syndrome; 6. Developming infrastructure; 7. Immunotherapy toxicities; 8. Checkpoint inhibitors; 9. Toxicity managment; 10.Oncolytic viruses
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
This report focuses on investment in research focused on cancer risk and prevention over a three-year period. Research is critiical to our understanding of cancer risk and effective cancer prevention strategies. The investment in cancer risk and prevention at $122.3M represented 11% of the overal…
c.1 BC Cancer Agency VAN Library | Available |